scholarly journals Heavy Metal Content in Thoracic Tissue Samples from Patients with and without NSCLC

2014 ◽  
Vol 2014 ◽  
pp. 1-6 ◽  
Author(s):  
Jessica Q. Tran ◽  
Alexandra Dranikov ◽  
Anita Iannucci ◽  
Walter P. Wagner ◽  
Janine LoBello ◽  
...  
Keyword(s):  
Heavy Metals ◽  
Heavy Metal ◽  
Small Cell ◽  
Cancer Growth ◽  
Small Cell Lung ◽  
Nsclc Tissue ◽  
Tissue Samples ◽  
Measurable Amount ◽  
Nsclc Patients ◽  
Sample Set

Objectives. Environmental factors expose an individual to heavy metals that may stimulate cancer growth preclinically including non-small cell lung cancer (NSCLC) cells. Here, we examine the prevalence of four heavy metals present in postsurgical tissues from individuals with and without NSCLC. Materials and Methods. Thoracic tissue samples from two separate sample sets were analyzed for cadmium (Cd), arsenic (As), mercury (Hg), and lead (Pb) content. Results. In the first sample set, there was no significant measurable amount of Pb and Hg found in either NSCLC tissue or nonmalignant lung tissue samples. Cd was the most prevalent heavy metal and As was present in moderate amounts. In the second sample set, Cd was measurable across all tissue types taken from 28 NSCLC patients and significantly higher Cd was measurable in noncancer benign lung (n=9). In the NSCLC samples, As was measurable in moderate amounts, while Hg and Pb amounts were negligible. Conclusion. Cd and As are present in lung tissues for patients with NSCLC. With existing preclinical evidence of their tumorigenecity, it is plausible that Cd and/or As may have an impact on NSCLC development. Additional studies examining the prevalence and association between smokers and nonsmokers are suggested.

B3GNT3 overexpression is associated with unfavourable survival in non-small cell lung cancer

2018 ◽  
Vol 71 (7) ◽  
pp. 642-647 ◽  
Author(s):  
Liuwei Gao ◽  
Hua Zhang ◽  
Bin Zhang ◽  
Jinfang Zhu ◽  
Chen Chen ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Disease Free Survival ◽  
Small Cell ◽  
Clinicopathological Parameters ◽  
Small Cell Lung ◽  
Nsclc Tissue ◽  
Clinical Prognosis ◽  
Nsclc Patients

ObjectiveThe aim of this study was to evaluate the expression of beta-1,3-N-acetylglucosaminyltransferase-3 (B3GNT3) in non-small cell lung cancer (NSCLC) patients and to investigate the relevance of B3GNT3 expression in tumour prognosis.MethodsIn this study, B3GNT3 expression was examined in five pairs of resectable NSCLC tissue by Western blot and in 42 pairs of resectable NSCLC tissue by quantitative real-time PCR (qRT-PCR). Immunohistochemistry and statistical analysis were performed to assess the relationship between B3GNT3 expression scores and clinicopathological parameters, as well as clinical prognosis in a retrospective cohort of 176 NSCLC patients.ResultsBoth B3GNT3 mRNA and protein expression levels were significantly higher in NSCLC tissue than in adjacent normal tissue. In the 176 NSCLC cases, a high B3GNT3 expression level was positively correlated with lymph node metastasis (P<0.001) and advanced TNM stage (P=0.043). Kaplan-Meier analysis indicated that patients with high B3GNT3 expression had significantly lower disease-free survival (DFS) (P<0.001) and overall survival (OS) (P<0.001) than those with low B3GNT3 expression. Moreover, in the multivariate analyses, B3GNT3 expression was an independent prognostic factor for DFS (HR 0.329, 95% CI 0.213 to 0.508, P<0.001) and OS (HR 0.383, 95% CI 0.249 to 0.588, P<0.001).ConclusionsOur study demonstrated that high expression of B3GNT3 was associated with unfavourable DFS and OS in NSCLC patients, suggesting that B3GNT3 might be a potential prognostic biomarker for NSCLC.

scholarly journals Prognostic significance of CD276 in non-small cell lung cancer

Open Medicine ◽  
2019 ◽  
Vol 14 (1) ◽  
pp. 805-812
Author(s):  
Changgong Zhang ◽  
Xuezhi Hao
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Expression Level ◽  
Normal Lung ◽  
Small Cell Lung ◽  
Nsclc Tissue ◽  
Normal Tissues ◽  
Nsclc Patients

AbstractBackgroundThe expression and significance of CD276 in non-small cell lung cancer (NSCLC) was explored.MethodThe BioGPS database was used to analyze the expression level of CD276 in normal tissues. Studies on the expression of CD276 in NSCLC patients using the Oncomine database. The prognostic roles of CD276 in NSCLC was studied using the Kaplan-Meier plotter database.ResultThe BioGPS database showed CD276 expression in all the human normal tissues. Compared with normal lung tissue, CD276 gene highly expressed in NSCLC tissue at mRNA level (P<0.05). The expression level of CD276 gene was negatively correlated with overall survival (OS) of NSCLC patients. Subgroup analysis showed that CD276 expression level had a significant effect on OS of patients with lung adenocarcinoma, while in squamous cell carcinoma its expression level had no significant effect on OS.ConclusionAccording to the information mined from the tumor gene database, CD276 mRNA was found highly expressed in NSCLC tissue and the expression of CD276 has a significant impact on survival of NSCLC patients, which provides an important theoretical basis for further study of the role of CD276 in the occurrence and development of NSCLC.

scholarly journals Identification of Differential Genes by Microarray and COL6A1 Induced the Bone Metastasis of Non-Small Cell Lung Cancer

2020 ◽  
Author(s):  
Nan Li ◽  
Xiaohui Cao ◽  
Wei Li ◽  
Yunfang Li ◽  
Zongmao Zhao ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Bone Metastasis ◽  
Western Blot ◽  
Pathway Analysis ◽  
Small Cell ◽  
Small Cell Lung ◽  
Nsclc Tissue ◽  
Alizarin Red ◽  
Tissue Samples ◽  
Adhesion Ability

Abstract Background: Non-small cell lung cancer (NSCLC) is a major cause of cancer-related death worldwide with bone metastasis as the most prevalent events in advanced cancer patients. However, its pathogenesis has not been clearly described. Methods: In the present study, differentially expressed genes (DEGs) were filtered through gene expression microarray between NSCLC tissue samples with or without bone metastasis. Subsequently, collagen family collagen 6A1 (COL6A1) was chosen as the target gene through Ingenuity Pathway Analysis and qRT-PCR validation of the 8 Top genes. And we evaluated the osteogenic capacity of HOB and hES-MP 002.5 cells through RT-qPCR, Western blot, Alizarin Red Staining and ALP staining.Results: A total of 364 DEGs including 140 up-regulated genes and 224 down-regulated genes were identified in NSCLC tissues with bone metastasis. GO analysis indicated that the upregulated and downregulated genes were mainly enriched in cellular process, metabolic process and biological regulation. KEGG pathway analysis revealed that the upregulated genes were mainly concentrated in cysteine and methionine metabolism, oxidative phosphorylation, and ribosome; the downregulated genes were mainly concentrated in the transcriptional misregulation in cancer, ribosome, and mitophagy-animal. Besides, the results of RT-qPCR, western blot and immunohistochemistry proved that COL6A1 was highly expressed in NSCLC tissue samples with bone metastasis. And we revealed that HOB and hES-MP 002.5 cells have osteogenic capacity through RT-qPCR, Western blot, Alizarin Red Staining and ALP staining . Moreover, the results of cell adhesion assay also proved that high expression of COL6A1 in HARA-B cells can induce its adhesion ability on osteoblasts, and low expression of COL6A1 in HARA-B cells can reduce its adhesion ability on osteoblasts. Conclusions: Therefore, our data revealed that the COL6A1 might represent a diagnostic marker or therapeutic target for bone metastasis in NSCLC.

scholarly journals LncRNA MIR210HG Facilitates Non-Small Cell Lung Cancer Progression Through Directly Regulation of miR-874/STAT3 Axis

Dose-Response ◽  
2020 ◽  
Vol 18 (3) ◽  
pp. 155932582091805
Author(s):  
Liang Bu ◽  
Libin Zhang ◽  
Mei Tian ◽  
Zhoubin Zheng ◽  
Huijie Tang ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Nsclc Cell ◽  
Migration And Invasion ◽  
Small Cell Lung ◽  
Nsclc Tissue ◽  
Tissue Samples ◽  
Cell Progression

Background: Long noncoding RNAs are involved in the progression of multiple cancers. However, the expression and mechanism of microRNA (miR)210HG in non-small cell lung cancer (NSCLC) remain unclear. Methods: The levels of miR210HG and miR-874 were measured by quantitative real-time polymerase chain reaction in NSCLC tissue samples and cells. Non-small cell lung cancer cell proliferation, migration, and invasion were measured by Cell Counting Kit-8 and transwell assays. Luciferase analysis confirmed the interaction between miR210HG and miR-874. Results: Here, our data showed that miR210HG was overexpressed in NSCLC tissue samples and cells. In vitro functional assays showed that silencing miR210HG blocked NSCLC cell proliferation, migration, and invasion while promoting NSCLC cell radiosensitivity and chemoresistance. Mechanistically, miR-874 was directly regulated by miR210HG. Furthermore, miR-874 expression was reduced in NSCLC tissues and cells. The miR-874 mimic could mitigate the promoting effect of miR210HG on NSCLC cell progression. The data also showed that miR210HG promoted NSCLC cell progression through miR-181a expression by targeting STAT3. Conclusions: Our observations suggest that miR210HG is associated with NSCLC cell progression by regulating the miR-874/STAT3 axis.

Curcumin increases crizotinib sensitivity through the inactivation of autophagy via epigenetic modulation of the miR-142-5p/Ulk1 axis in non-small cell lung cancer

2021 ◽  
pp. 1-11
Author(s):  
Yu-Zheng He ◽  
Shan-Ling Yu ◽  
Xiao-Ning Li ◽  
Xian-Hua Bai ◽  
Hai-Tao Li ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Critical Factor ◽  
Underlying Mechanism ◽  
Small Cell ◽  
Small Cell Lung ◽  
Nsclc Tissue ◽  
Tissue Samples ◽  
H460 Cells

Drug resistance is a critical factor responsible for the recurrence of non-small cell lung cancer (NSCLC). Previous studies suggest that curcumin acts as a chemosensitizer and radiosensitizer in human malignancies, but the underlying mechanism remains elusive. In the present study, we explored how curcumin regulates the expression of miR-142-5p and sensitizes NSCLC cells to crizotinib. We found that miR-142-5p is significantly downregulated in NSCLC tissue samples and cell lines. Curcumin could increase crizotinib cytotoxicity by epigenetically restoring the expression of miR-142-5p. Furthermore, curcumin treatment suppressed the expression of DNA methylation-related enzymes, including DNMT1, DNMT3A, and DNMT3B, in NSCLC cells. In addition, the upregulation of miR-142-5p expression increased crizotinib cytotoxicity and induced apoptosis in tumor cells in a similar manner to that of curcumin. Strikingly, miR-142-5p overexpression suppressed crizotinib-induced autophagy in A549 and H460 cells. Mechanistically, miR-142-5p inhibited autophagy in lung cancer cells by targeting Ulk1. Overexpression of Ulk1 abrogated the miR-142-5p-induced elevation of crizotinib cytotoxicity in A549 and H460 cells. Collectively, our findings demonstrate that curcumin sensitizes NSCLC cells to crizotinib by inactivating autophagy through the regulation of miR-142-5p and its target Ulk1.

Sign in / Sign up

Export Citation Format

Share Document